SANOFI (SNW.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SNW - FR0000120578 - Common Stock
86.45 EUR
+0.05 (+0.06%)
Taking everything into account, SNW scores 6 out of 10 in our fundamental rating. SNW was compared to 55 industry peers in the Pharmaceuticals industry. SNW scores excellent on profitability, but there are some minor concerns on its financial health. SNW has a correct valuation and a medium growth rate. Finally SNW also has an excellent dividend rating. With these ratings, SNW could be worth investigating further for dividend investing!.
1. Profitability
1.1 Basic Checks
In the past year SNW was profitable.
In the past year SNW had a positive cash flow from operations.
In the past 5 years SNW has always been profitable.
Each year in the past 5 years SNW had a positive operating cash flow.
1.2 Ratios
The Return On Assets of SNW (11.05%) is better than 78.18% of its industry peers.
Looking at the Return On Equity, with a value of 19.73%, SNW is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
SNW has a better Return On Invested Capital (13.84%) than 69.09% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SNW is significantly below the industry average of 14.90%.
The 3 year average ROIC (7.31%) for SNW is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
SNW's Profit Margin of 20.35% is fine compared to the rest of the industry. SNW outperforms 80.00% of its industry peers.
In the last couple of years the Profit Margin of SNW has grown nicely.
The Operating Margin of SNW (23.59%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of SNW has grown nicely.
SNW has a Gross Margin of 71.70%. This is comparable to the rest of the industry: SNW outperforms 50.91% of its industry peers.
SNW's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SNW is creating value.
SNW has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for SNW remains at a similar level compared to 5 years ago.
SNW has a better debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of SNW is 2.21, which is a good value as it means it would take SNW, 2.21 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.21, SNW belongs to the top of the industry, outperforming 87.27% of the companies in the same industry.
SNW has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.21, SNW is doing good in the industry, outperforming 78.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC7.65%
2.3 Liquidity
SNW has a Current Ratio of 1.27. This is a normal value and indicates that SNW is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, SNW perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
A Quick Ratio of 0.94 indicates that SNW may have some problems paying its short term obligations.
SNW has a Quick ratio (0.94) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
The earnings per share for SNW have decreased by -5.35% in the last year.
The Earnings Per Share has been growing slightly by 5.10% on average over the past years.
SNW shows a small growth in Revenue. In the last year, the Revenue has grown by 2.56%.
Measured over the past years, SNW shows a small growth in Revenue. The Revenue has been growing by 3.31% on average per year.
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
3.2 Future
The Earnings Per Share is expected to grow by 7.11% on average over the next years.
The Revenue is expected to grow by 4.55% on average over the next years.
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.38 indicates a reasonable valuation of SNW.
SNW's Price/Earnings ratio is rather cheap when compared to the industry. SNW is cheaper than 81.82% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.15, SNW is valued rather cheaply.
SNW is valuated reasonably with a Price/Forward Earnings ratio of 10.07.
78.18% of the companies in the same industry are more expensive than SNW, based on the Price/Forward Earnings ratio.
SNW's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.12.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.38 | ||
| Fwd PE | 10.07 |
4.2 Price Multiples
63.64% of the companies in the same industry are more expensive than SNW, based on the Enterprise Value to EBITDA ratio.
SNW's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNW is cheaper than 61.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.85 | ||
| EV/EBITDA | 11.07 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SNW may justify a higher PE ratio.
PEG (NY)3.71
PEG (5Y)2.23
EPS Next 2Y5.75%
EPS Next 3Y6.01%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.59%, SNW is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.00, SNW pays a better dividend. On top of this SNW pays more dividend than 89.09% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SNW pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
5.2 History
The dividend of SNW has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
34.82% of the earnings are spent on dividend by SNW. This is a low number and sustainable payout ratio.
The dividend of SNW is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
FRA:SNW (11/26/2025, 7:00:00 PM)
86.45
+0.05 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners47.5%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap209.99B
Revenue(TTM)66.91B
Net Income(TTM)13.81B
Analysts81.38
Price Target108.63 (25.66%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.59% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-2.29%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.29%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)2.17%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)11
Avg EPS beat(16)3.44%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-0.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.12%
Revenue beat(12)5
Avg Revenue beat(12)9.77%
Revenue beat(16)9
Avg Revenue beat(16)21.47%
PT rev (1m)-0.86%
PT rev (3m)-0.1%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-6.91%
EPS NY rev (1m)-1.01%
EPS NY rev (3m)-4.9%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0.96%
Revenue NY rev (3m)-0.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.38 | ||
| Fwd PE | 10.07 | ||
| P/S | 3.09 | ||
| P/FCF | 20.85 | ||
| P/OCF | 18.45 | ||
| P/B | 3 | ||
| P/tB | 22.59 | ||
| EV/EBITDA | 11.07 |
EPS(TTM)7.6
EY8.79%
EPS(NY)8.59
Fwd EY9.93%
FCF(TTM)4.15
FCFY4.8%
OCF(TTM)4.69
OCFY5.42%
SpS27.95
BVpS28.82
TBVpS3.83
PEG (NY)3.71
PEG (5Y)2.23
Graham Number70.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexgc growth 3Y-13.63%
ROICexgc growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.65%
ROIC/WACC1.81
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.35%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%1.75%
EPS Next Y3.07%
EPS Next 2Y5.75%
EPS Next 3Y6.01%
EPS Next 5Y7.11%
Revenue 1Y (TTM)2.56%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.47%
Revenue Next Year0.53%
Revenue Next 2Y3.48%
Revenue Next 3Y4.4%
Revenue Next 5Y4.55%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year30.73%
EBIT Next 3Y13.89%
EBIT Next 5Y11.66%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%
SANOFI / SNW.DE FAQ
Can you provide the ChartMill fundamental rating for SANOFI?
ChartMill assigns a fundamental rating of 6 / 10 to SNW.DE.
Can you provide the valuation status for SANOFI?
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SNW.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SANOFI?
SANOFI (SNW.DE) has a profitability rating of 7 / 10.
What is the financial health of SANOFI (SNW.DE) stock?
The financial health rating of SANOFI (SNW.DE) is 5 / 10.
What is the expected EPS growth for SANOFI (SNW.DE) stock?
The Earnings per Share (EPS) of SANOFI (SNW.DE) is expected to grow by 3.07% in the next year.